Integrative Molecular Epidemiology Workshop

综合分子流行病学研讨会

基本信息

项目摘要

DESCRIPTION (provided by applicant): The American Association for Cancer Research (AACR) requests NCI support for an innovative, unique, and intensive one-week educational experience (Integrative Molecular Epidemiology Workshop) to be repeated annually to accelerate the training of the next generation of cancer researchers who must be well-skilled in the integration of biology and epidemiology in studies of etiology and outcome. Of particular importance is the need to educate researchers in integrating modern and rapidly evolving "omics" technologies into state-of-the-art molecular epidemiology, as well the need to become facile in integrating diverse and high dimensional data. The Workshop is primarily targeted toward molecular epidemiologists, but the materials are designed to also be appropriate for geneticists, statisticians, bioinformaticians, molecular biologists, physician scientists and other who have completed basic coursework in epidemiology. The highly qualified faculty assembled to teach this workshop have expertise that spans these disciplines ensuring that all materials are of the highest quality and the most relevant content. The program will be reviewed annually by distinguished scientists who serve on the Board of Directors of the AACR, a scientific society of 35,638 members worldwide working in all aspects of basic, clinical, and translational cancer research. It is expected that the majority of the 50 attendees will be postdoctoral fellows and junior faculty, but a few advanced graduate students and mid-level/senior faculty will be eligible to participate. Based on our experiences with other courses, we expect the application process to be highly competitive, with at least twice the number of applications for the slots available. What will distinguish the focus of the workshop is the application of these technologies and approaches within an epidemiologic framework. Thus, all lectures and laboratories will be cognizant of issues like feasibility, scalability, quality control, and practical limitations. Forml didactic lectures will take place in the mornings with extensive time for discussion. Afternoons will be devoted to "laboratories" building upon the information provided in the morning lectures with problem- solving sessions and "hands-on" applications of statistical and bioinformatics methods. Participants will work collaboratively in small groups throughout the duration of the workshop. Cooperative group learning and problem solving activities will be used to ensure lively and active discussion with engaged learners. Finally, we will evaluate learning with measurable outcomes for the workshop overall and for individual lectures and laboratories. AACR has experienced staff and an excellent track record for administering other educational Workshops.
描述(由申请人提供):美国癌症研究协会(AACR)要求NCI支持一年的创新,独特和密集的一周教育经验(整合分子流行病学研讨会),以加速对下一代癌症研究人员的培训,这些癌症研究人员必须在生物学和流行学研究中都得到很好的综合研究和Etii eTii of Etii&Etii of Etii of Etii of Etii&Etii of Etii of Etii&Etii of Etii of Etii&Etii of Etii of I.特别重要的是,需要教育研究人员将现代和快速发展的“ OMIC”技术整合到最先进的分子流行病学中,并需要在整合多样化和高维数据方面便利。该研讨会主要针对分子流行病学家,但材料旨在适合遗传学家,统计学家,生物信息学家,分子生物学家,医师科学家以及其他已经完成流行病学基础课程的工作。高素质的教职员工教授该研讨会的专业知识,可以跨越这些学科,以确保所有材料具有最高质量和最相关的内容。该计划将每年审查杰出科学家,他们在AACR董事会任职,这是一个科学学会,该学会在全球范围内有35,638名成员,在基础,临床和转化癌症研究的各个方面工作。预计50名与会者中的大多数将是博士后研究员和初级教师,但是一些高级研究生和中级/高级教师将有资格参加。根据我们在其他课程中的经验,我们希望申请过程具有很高的竞争力,至少是可用插槽的申请次数的两倍。区别研讨会的重点是在流行病学框架内应用这些技术和方法。因此,所有讲座和实验室都将认识到可行性,可伸缩性,质量控制和实际限制等问题。形式教学讲座将在早晨进行,并进行大量讨论。下午将介绍“实验室”基础上的早晨讲座中提供的信息,并通过解决问题的会议和统计和生物信息学方法的“动手”申请。参与者将在整个研讨会的过程中以小组的方式进行合作。合作小组学习和解决问题的活动将用于确保与参与学习者的活泼和积极的讨论。最后,我们将通过可测量的成果评估整个研讨会以及各个讲座和实验室的学习。 AACR经验丰富的员工和出色的往绩记录,用于管理其他教育研讨会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS A SELLERS其他文献

THOMAS A SELLERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS A SELLERS', 18)}}的其他基金

Integrative Molecular Epidemiology Workshop
综合分子流行病学研讨会
  • 批准号:
    8475082
  • 财政年份:
    2013
  • 资助金额:
    $ 19.74万
  • 项目类别:
Integrative Molecular Epidemiology Workshop
综合分子流行病学研讨会
  • 批准号:
    8710110
  • 财政年份:
    2013
  • 资助金额:
    $ 19.74万
  • 项目类别:
PROGRAM LEADERS
项目负责人
  • 批准号:
    8709216
  • 财政年份:
    2013
  • 资助金额:
    $ 19.74万
  • 项目类别:
ADMINISTRATION
行政
  • 批准号:
    8530504
  • 财政年份:
    2012
  • 资助金额:
    $ 19.74万
  • 项目类别:
ADMINISTRATION
行政
  • 批准号:
    8532103
  • 财政年份:
    2012
  • 资助金额:
    $ 19.74万
  • 项目类别:
Automated DNA Extraction System
自动化DNA提取系统
  • 批准号:
    8052611
  • 财政年份:
    2011
  • 资助金额:
    $ 19.74万
  • 项目类别:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
  • 批准号:
    8504772
  • 财政年份:
    2010
  • 资助金额:
    $ 19.74万
  • 项目类别:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
  • 批准号:
    8871955
  • 财政年份:
    2010
  • 资助金额:
    $ 19.74万
  • 项目类别:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
  • 批准号:
    8104223
  • 财政年份:
    2010
  • 资助金额:
    $ 19.74万
  • 项目类别:
Functional assessment of genes and common genetic risk variants in ovarian cancer
卵巢癌基因和常见遗传风险变异的功能评估
  • 批准号:
    7933448
  • 财政年份:
    2010
  • 资助金额:
    $ 19.74万
  • 项目类别:

相似海外基金

Disparities in the Use of Oral Anticancer Agents in Kidney Cancer
肾癌口服抗癌药物使用的差异
  • 批准号:
    10306983
  • 财政年份:
    2021
  • 资助金额:
    $ 19.74万
  • 项目类别:
Disparities in the Use of Oral Anticancer Agents in Kidney Cancer
肾癌口服抗癌药物使用的差异
  • 批准号:
    10376266
  • 财政年份:
    2021
  • 资助金额:
    $ 19.74万
  • 项目类别:
Disparities in the Use of Oral Anticancer Agents in Kidney Cancer
肾癌口服抗癌药物使用的差异
  • 批准号:
    10545169
  • 财政年份:
    2021
  • 资助金额:
    $ 19.74万
  • 项目类别:
Patient Derived Cancer Model (PDCM) Finder
患者衍生癌症模型 (PDCM) 查找器
  • 批准号:
    10260591
  • 财政年份:
    2020
  • 资助金额:
    $ 19.74万
  • 项目类别:
Patient Derived Cancer Model (PDCM) Finder
患者衍生癌症模型 (PDCM) 查找器
  • 批准号:
    10058856
  • 财政年份:
    2020
  • 资助金额:
    $ 19.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了